Overview

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.
Phase:
N/A
Details
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Collaborators:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Harbin Medical University
Shandong Provincial Hospital
Treatments:
Capecitabine
Docetaxel